Changes in sST2 and NT-proBNP levels predict early cardiac arrhythmia in breast cancer patients treated with anthracycline-containing chemotherapies

BackgroundCardiovascular biomarkers are crucial for monitoring cancer therapy-related cardiac toxicity, but the effects on early stage are still inadequate. To screen biomarkers in patients with breast cancer who receive anthracycline-containing chemotherapy, we studied the behavior of six biomarker...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Cuncun Chen, Hui Zheng, Yanchun Wang, Ying Tong, Heng Zhang, Suhong Xie, Xiaolu Ma, Minglei Jiang, Zhiyun Gong, Tianqing Yan, Yanan Tian, Lin Guo, Renquan Lu
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Frontiers Media S.A. 2024-12-01
Saila:	Frontiers in Cardiovascular Medicine
Gaiak:	soluble ST2 NT-ProBNP cardiac toxicity arrhythmia chemotherapy
Sarrera elektronikoa:	https://www.frontiersin.org/articles/10.3389/fcvm.2024.1477679/full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!